|Posted: 2018-Aug-01 00:53 by Predator Research|
|Posted: 2018-Aug-28 17:44 by news bot|
PG has received approval from EU antitrust regulators for the 3.4 billion Euro acquisition of Merck’s consumer health unit.
[url="https://predatortradinggroup.com/viewtopic.php?f=4&t=24"]see this thread[/url]
|Posted: 2018-Oct-04 14:52 by news bot|
Craig Thompson has resigned from the board of Merck & Co. following a disclosure scandal.
"I have taken feedback from our staff and faculty seriously and intend to lead by example." Dr Thompson said in a statement.
|Posted: 2018-Oct-11 13:30 by news bot|
Credit Suisse has upgraded price target for Merck & Co to $81 from $71. Upside potential for Keytruda cited.
|Posted: 2018-Oct-22 13:01 by news bot|
BMO raises price target to $82 from $70 citing long-term growth potential for the Keytruda and Gardasil products.
|Posted: 2018-Oct-25 13:23 by news bot|
Merck is reporting earnings of $1.19 per share on revenues of $10.79 Billion for the quarter ending September 2018.
Analysts expected $1.16 per share on $10.85 Billion in sales.
The firm also announced an increase in the dividend to $0.55 per share and a $10 Billion stock buyback.